Stock HSCS HEART TEST LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-24 EDT 		5-day change 1st Jan Change
6.2 USD +12.12% Intraday chart for Heart Test Laboratories, Inc. +5.44% -63.74%
04-24 HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG CI
03-26 HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients CI

Valuation

Fiscal Period: April 2023 2024 2025 2026
Capitalization 1 8.644 4.065 - -
Enterprise Value (EV) 1 8.55 4.065 4.065 4.065
P/E ratio -1.11 x -0.31 x -0.59 x -
Yield - - - -
Capitalization / Revenue 1,678 x 68.5 x 2.14 x 0.35 x
EV / Revenue 1,678 x 68.5 x 2.14 x 0.35 x
EV / EBITDA -1.42 x -0.65 x -0.47 x -12.5 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book 30.6 x 0.44 x - -
Nbr of stocks (in thousands) 97.4 655.6 - -
Reference price 2 88.75 6.200 6.200 6.200
Announcement Date 23-07-19 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2022 2023 2024 2025 2026
Net sales 1 - 0.00515 0.0593 1.9 11.5
EBITDA 1 - -6.086 -6.236 -8.674 -0.326
EBIT 1 - -6.113 -6.31 -8.802 -0.35
Operating Margin - -118,698.25% -10,640.73% -463.29% -3.04%
Earnings before Tax (EBT) 1 - -6.354 -6.686 -9.039 -0.35
Net income 1 -4.828 -6.354 -6.686 -9.039 -0.35
Net margin - -123,384.27% -11,274.37% -475.76% -3.04%
EPS 2 -145.0 -80.00 -20.00 -10.50 -
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 22-07-29 23-07-19 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 0.0032 - 0.00195 - - - 0.0147 0.05 0.2 0.4 0.55 0.8
EBITDA 1 - -1.768 -1.302 -1.592 -1.323 -1.562 -1.522 -1.888 -2.228 -2.208 -2.368 -1.92
EBIT 1 -1.43 -1.775 -1.309 -1.599 -1.331 -1.57 -1.525 -1.9 -2.248 -2.228 -2.388 -1.94
Operating Margin -44,690.62% - -67,143.59% - - - -10,376.73% -3,800% -1,123.75% -556.88% -434.09% -242.5%
Earnings before Tax (EBT) 1 -1.573 -1.807 -1.342 -1.632 -1.367 -1.748 -1.644 -1.959 -2.307 -2.287 -2.447 -1.999
Net income 1 -1.573 -1.807 -1.342 -1.632 -1.367 -1.748 -1.644 -1.959 -2.307 -2.287 -2.447 -1.999
Net margin -49,165.62% - -68,826.67% - - - -11,182.38% -3,918.4% -1,153.35% -571.68% -444.85% -249.9%
EPS 2 -19.25 -22.00 -16.00 -16.00 -13.00 -16.00 -3.000 -3.500 -3.000 -3.000 -3.000 -2.000
Dividend per Share - - - - - - - - - - - -
Announcement Date 22-09-12 22-12-15 23-03-16 23-07-19 23-09-14 23-12-14 24-03-14 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - 0.09 - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - 2.900 14.00 - -
Cash Flow per Share - - - - -
Capex - 0.02 - - -
Capex / Sales - 355.53% - - -
Announcement Date 22-07-29 23-07-19 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Heart Test Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.2 USD
Average target price
67.5 USD
Spread / Average Target
+988.71%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Monitoring Systems

1st Jan change Capi.
HEART TEST LABORATORIES, INC. Stock Heart Test Laboratories, Inc.
-63.74% 4.06M
IRHYTHM TECHNOLOGIES, INC. Stock iRhythm Technologies, Inc.
-16.91% 2.77B
EKF DIAGNOSTICS HOLDINGS PLC Stock EKF Diagnostics Holdings plc
+3.32% 191M
MEDIANA CO.,LTD Stock MEDIANA Co.,Ltd
-20.28% 78.31M
PULSENMORE LTD. Stock Pulsenmore Ltd.
-48.20% 49.99M
Medical Monitoring Systems
  1. Stock Market
  2. Equities
  3. HSCS Stock
  4. Financials Heart Test Laboratories, Inc.